These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 16815997)

  • 21. Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity.
    Valvezan AJ; Zhang F; Diehl JA; Klein PS
    J Biol Chem; 2012 Feb; 287(6):3823-32. PubMed ID: 22184111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh; Lomvardas S; Costantini F
    Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular association between beta-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/beta-catenin signaling.
    Upadhyay G; Goessling W; North TE; Xavier R; Zon LI; Yajnik V
    Oncogene; 2008 Oct; 27(44):5845-55. PubMed ID: 18641688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis of the Axin-adenomatous polyposis coli interaction.
    Spink KE; Polakis P; Weis WI
    EMBO J; 2000 May; 19(10):2270-9. PubMed ID: 10811618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The low-density lipoprotein receptor-related protein 10 is a negative regulator of the canonical Wnt/beta-catenin signaling pathway.
    Jeong YH; Sekiya M; Hirata M; Ye M; Yamagishi A; Lee SM; Kang MJ; Hosoda A; Fukumura T; Kim DH; Saeki S
    Biochem Biophys Res Commun; 2010 Feb; 392(4):495-9. PubMed ID: 20093106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation.
    Zeng X; Tamai K; Doble B; Li S; Huang H; Habas R; Okamura H; Woodgett J; He X
    Nature; 2005 Dec; 438(7069):873-7. PubMed ID: 16341017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frat oncoproteins act at the crossroad of canonical and noncanonical Wnt-signaling pathways.
    van Amerongen R; Nawijn MC; Lambooij JP; Proost N; Jonkers J; Berns A
    Oncogene; 2010 Jan; 29(1):93-104. PubMed ID: 19802005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dual-role regulations of canonical Wnt/beta-catenin signaling pathway].
    Liu Y; Zhang CG; Zhou CY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):238-42. PubMed ID: 20396373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.
    Amit S; Hatzubai A; Birman Y; Andersen JS; Ben-Shushan E; Mann M; Ben-Neriah Y; Alkalay I
    Genes Dev; 2002 May; 16(9):1066-76. PubMed ID: 12000790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells.
    Helmbrecht K; Kispert A; von Wasielewski R; Brabant G
    Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bili inhibits Wnt/beta-catenin signaling by regulating the recruitment of axin to LRP6.
    Kategaya LS; Changkakoty B; Biechele T; Conrad WH; Kaykas A; Dasgupta R; Moon RT
    PLoS One; 2009 Jul; 4(7):e6129. PubMed ID: 19572019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible modification of adenomatous polyposis coli (APC) with K63-linked polyubiquitin regulates the assembly and activity of the β-catenin destruction complex.
    Tran H; Polakis P
    J Biol Chem; 2012 Aug; 287(34):28552-63. PubMed ID: 22761442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of intrinsic disorder in orchestrating the Wnt-pathway.
    Xue B; Dunker AK; Uversky VN
    J Biomol Struct Dyn; 2012; 29(5):843-61. PubMed ID: 22292947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway.
    Hay E; Faucheu C; Suc-Royer I; Touitou R; Stiot V; Vayssière B; Baron R; Roman-Roman S; Rawadi G
    J Biol Chem; 2005 Apr; 280(14):13616-23. PubMed ID: 15699046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mitogen-activated protein kinase kinase kinase kinase GCKR positively regulates canonical and noncanonical Wnt signaling in B lymphocytes.
    Shi CS; Huang NN; Harrison K; Han SB; Kehrl JH
    Mol Cell Biol; 2006 Sep; 26(17):6511-21. PubMed ID: 16914735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MENA is a transcriptional target of the Wnt/beta-catenin pathway.
    Najafov A; Seker T; Even I; Hoxhaj G; Selvi O; Ozel DE; Koman A; Birgül-İyison N
    PLoS One; 2012; 7(5):e37013. PubMed ID: 22615875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconstituting regulation of the canonical Wnt pathway by engineering a minimal β-catenin destruction machine.
    Pronobis MI; Deuitch N; Posham V; Mimori-Kiyosue Y; Peifer M
    Mol Biol Cell; 2017 Jan; 28(1):41-53. PubMed ID: 27852897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dab2 stabilizes Axin and attenuates Wnt/beta-catenin signaling by preventing protein phosphatase 1 (PP1)-Axin interactions.
    Jiang Y; Luo W; Howe PH
    Oncogene; 2009 Aug; 28(33):2999-3007. PubMed ID: 19581931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GSKIP is homologous to the Axin GSK3beta interaction domain and functions as a negative regulator of GSK3beta.
    Chou HY; Howng SL; Cheng TS; Hsiao YL; Lieu AS; Loh JK; Hwang SL; Lin CC; Hsu CM; Wang C; Lee CI; Lu PJ; Chou CK; Huang CY; Hong YR
    Biochemistry; 2006 Sep; 45(38):11379-89. PubMed ID: 16981698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.